ClinicalTrials.Veeva

Menu

Identification of Modifying Factors in Hereditary Spastic Paraplegia (MODIFSPA2)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Hereditary Spastic Paraplegia

Treatments

Other: questionnaire completion

Study type

Observational

Funder types

Other

Identifiers

NCT05373082
APHP211621

Details and patient eligibility

About

A first questionnaire - MODIFSPA conducted in 2014 - identified several environmental factors influencing spasticity in HSP: cold, fatigue, and especially physical activity. In order to improve the care of patients with HSP, The investigator team are looking to deepen the knowledge on physical exercises relieving spasticity as well as to better know the frequency of symptoms requiring additional medical care: fatigue and vesico-sphincter disorders. A new questionnaire was therefore created to collect additional information to optimize the care of patients with HSP.

Full description

The only common symptom of hereditary spastic paraplegia (HSP) is the presence of spasticity in the lower limbs, associated with a great clinical and genetic heterogeneity.

A first MODIFSPA study carried out by the team identified environmental factors influencing spasticity: stress, fatigue, physical activity. In this first study, only spasticity was studied but several symptoms appeared to require medical management according to the patients: fatigue and vesico-sphincter disorders.

Following this first study, MODIFSPA2 aims to deepen our knowledge of HSP, via the expertise of patients, to propose a care in adequacy with their needs/demands.

Validated scales are included in the questionnaire to evaluate the frequency and intensity of the symptoms most reported by patients (fatigue, pain and mood disorders). Questions are asked to better know the frequency of symptoms requiring additional medical care: fatigue and vesico-sphincter disorders.

Enrollment

311 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • French-speaking adult patients aware of their PSH diagnosis coming to the genetic consultation at the Pitié-Salpêtrière Hospital or informed via an association / website of the BRAINTEAM study network
  • Affiliated with social security

Exclusion criteria

  • NA

Trial design

311 participants in 1 patient group

Patients with hereditary spastic Paraplegia
Description:
Patients with hereditary spastic Paraplegia
Treatment:
Other: questionnaire completion

Trial contacts and locations

1

Loading...

Central trial contact

Hilab Rania; Lallemant Pauline, MD, PH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems